BYTIVITI Trademark

Trademark Overview

On Thursday, December 18, 2014, a trademark application was filed for BYTIVITI with the United States Patent and Trademark Office. The USPTO has given the BYTIVITI trademark a serial number of 86484919. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 10, 2023. This trademark is owned by AstraZeneca AB. The BYTIVITI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
bytiviti

General Information

Serial Number86484919
Word MarkBYTIVITI
Filing DateThursday, December 18, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 10, 2023
Registration Number5005811
Registration DateTuesday, July 26, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, February 10, 2023CANCELLED SEC. 8 (6-YR)
Monday, July 26, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 26, 2016REGISTERED-PRINCIPAL REGISTER
Saturday, June 18, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, April 25, 2016NOTICE OF ALLOWANCE CANCELLED
Sunday, June 12, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 25, 2016TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, December 22, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 27, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 7, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 22, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 21, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 19, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 14, 2015ASSIGNED TO LIE
Thursday, August 27, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 27, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 27, 2015NON-FINAL ACTION E-MAILED
Friday, March 27, 2015NON-FINAL ACTION WRITTEN
Friday, March 27, 2015ASSIGNED TO EXAMINER
Tuesday, December 23, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 22, 2014NEW APPLICATION ENTERED

Related Keywords

bytiviti diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal